Major US study findings.

NIH scientists find clinicians still rely often on older and toxic medicines.

Since 2018, WHO has recommended use of dolutegravir as the preferred first- and second-line HIV treatment for all population groups.

Proteogenomics provides clues about acute myeloid leukemia.

New study from Sylvester Cancer and collaborators shows anti-cancer compound goes beyond current BTK inhibitors.

More infectious version of bacteria found to have caused two outbreaks in a children’s hospital in China.

WHO guidance.

AMR occurs when bacteria, viruses, fungi and parasites no longer respond to the active ingredients, or antimicrobial agents, in medicines used to treat them.

The relentless rise in curable bacterial sexually transmitted infections (STIs) across the United States is an urgent public health crisis.1 In the latest report from the Centers...

Researchers study confluence of multidrug resistance and hypervirulence among Klebsiella pneumoniae.